These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14114175)
1. HYPERLIPAEMIC XANTHOMATOSIS TREATED WITH CLOFIBRATE. 'DRY DISCOID ECZEMA'. SHARVILL DE Proc R Soc Med; 1964 Jan; 57(1):44-5. PubMed ID: 14114175 [No Abstract] [Full Text] [Related]
2. THE TREATMENT OF XANTHOMATOSIS WITH ATROMID. BORRIE P Br J Dermatol; 1964 Feb; 76():53-5. PubMed ID: 14119261 [No Abstract] [Full Text] [Related]
3. THE TREATMENT OF XANTHOMATOSIS WITH "ATROMID". MISHKEL MA Med J Aust; 1964 Nov; 2():828-33. PubMed ID: 14226559 [No Abstract] [Full Text] [Related]
4. [THE ACTION OF CLOFIBRATE-ANDROSTERONE ON THE PLASMA CHOLESTEROL AND LIPIDS]. VASTESAEGER M; GILLOT P; DELCOURT R Brux Med; 1964 Aug; 44():357-75. PubMed ID: 14196801 [No Abstract] [Full Text] [Related]
5. THE EFFECT OF ATROMID IN ESSENTIAL HYPERLIPAEMIA. HARRISON MT; GOLDBERG DM J Atheroscler Res; 1963; 3():561-5. PubMed ID: 14100899 [No Abstract] [Full Text] [Related]
6. THE EFFECTS OF ATROMID ON SERUM CHOLESTEROL, SERUM TRIGLYCERIDES, AND RADIOACTIVE FAT TOLERANCE IN PATIENTS WITH HYPERLIPIDEMIA. A PRELIMINARY REPORT. BERKOWITZ D J Atheroscler Res; 1963; 3():538-41. PubMed ID: 14100895 [No Abstract] [Full Text] [Related]
7. EFFECT OF CLOFIBRATE AND ANDROSTERONE ON HYPERCHOLESTEROLAEMIC XANTHOMATOSIS. MASON B; PERRY CB Br Med J; 1965 Jan; 1(5427):102-3. PubMed ID: 14218460 [No Abstract] [Full Text] [Related]
8. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
9. Clofibrate in the management of a case of lipoid dermato-arthritis: a clinical and metabolic study. Golding DN Ann Rheum Dis; 1968 Sep; 27(5):475-6. PubMed ID: 5677165 [No Abstract] [Full Text] [Related]
10. [Inborn errors of lipid metabolism. Effect of clofibrate on the level of blood lipids of patients with familial hyperlipoproteinemia (type 2, 3 and 4)]. Sobra J; Heyrovský A; Sulc M; Horáková D Cas Lek Cesk; 1969 Aug; 108(36):1065-9. PubMed ID: 5807234 [No Abstract] [Full Text] [Related]
11. THE TREATMENT OF HYPERCHOLESTEROLAEMIC XANTHOMATOSIS WITH ATROMID. JEPSON EM; JAMES DC J Atheroscler Res; 1963; 3():554-60. PubMed ID: 14100898 [No Abstract] [Full Text] [Related]
12. [FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA]. FAIVRE G; GILGENKRANTZ JM; CHERRIER F; HENRY C Coeur Med Interne; 1963 Oct; 58():405-11. PubMed ID: 14092610 [No Abstract] [Full Text] [Related]
13. [HYPOCHOLESTEROLEMIANTS IN PEDIATRICS. STUDY OF THEIR EFFECTS IN NORMAL CHILDREN AND IN SOME DISEASES WITH HYPERLIPEMIA]. MARQUEZ LA Sem Med; 1963 Aug; 123():521-9. PubMed ID: 14092031 [No Abstract] [Full Text] [Related]
14. [Serum cholesterol and total serum lipids of psoriasis patients in comparison with healthy persons and other diseases]. Ruhrmann H Hautarzt; 1972 Oct; 23(10):451-4. PubMed ID: 5087128 [No Abstract] [Full Text] [Related]
15. [CONGENITAL DISORDERS OF LIPID METABOLISM. XII. HYPOCHOLESTEREMIC EFFECT OF TRIPARANOL]. SOBRA J Lek Veda Zahr; 1964 Jan; 1():14-8. PubMed ID: 14130761 [No Abstract] [Full Text] [Related]
16. [ATROMID IN HYPERCHOLESTEROLEMIA AND HYPERLIPEMIA. LITERATURE REVIEW AND RESULTS OF CLINICAL TESTS]. ENGSTROEM J Sven Lakartidn; 1964 Apr; 61():1446-57. PubMed ID: 14145138 [No Abstract] [Full Text] [Related]